Tetrahydrofurfuryl acetate
Common Name: |
Tetrahydrofurfuryl acetate |
IUPAC Name: |
oxolan-2-ylmethyl acetate |
Molecular Formula: |
C7H12O3 |
SMILES: |
CC(=O)OCC1CCCO1 |
Inchi: |
1S/C7H12O3/c1-6(8)10-5-7-3-2-4-9-7/h7H,2-5H2,1H3 |
Inchi Key: |
AAQDYYFAFXGBFZ-UHFFFAOYSA-N |
Cas No: |
637-64-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
144.17 |
Mass (g/mol) |
144.079 |
Molar Refractivity |
36.02 |
Net Charge |
|
HBD |
|
HBA |
3 |
Rt Bonds |
3 |
Rings |
1 |
TPSA |
35.53 |
Hetero Atoms |
3 |
Heavy Atoms |
10 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
194.00 to 195.00 @ 753.00 mm Hg |
Vapor Pressure (mmHg@25.00 °C) |
0.249 |
Vapor Density (Air =1) |
4.9 |
Fraction Csp3 |
0.86 |
LogP |
0.728 |
iLOGP |
2.09 |
XLOGP3 |
0.52 |
WLOGP |
0.73 |
MLOGP |
0.35 |
ESOL Log S |
-0.86 |
ESOL Solubility (mg/ml) |
19.7 |
ESOL Solubility (mol/l) |
0.137 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-0.84 |
Ali Solubility (mg/ml) |
21 |
Ali Solubility (mol/l) |
0.15 |
Ali Class |
Very soluble |
Silicos-IT LogSw |
-0.96 |
Silicos-IT Solubility (mg/ml) |
15.9 |
Silicos-IT Solubility (mol/l) |
0.11 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-6.81 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.426 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
1 |
Acute Oral Toxicity |
1.345 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |